GWPH News and Press, GW Pharmaceuticals Plc From 02/19/21

The trading week was a little shorter as markets celebrated President day on Monday. However, there was still big news this week. Verano Holdings began trading on the CSE this week using the symbol VRNO after closing the reverse takeover of Alternative Medi...

In the first marijuana industry buyout of 2021, Jazz Pharmaceuticals (NASDAQ: JAZZ) agreed to pay a hefty $7.6 billion to acquire GW Pharmaceuticals (NASDAQ: GWPH) , a developer of cannabis-based medications. Will their fortunes suddenly change if the U.S. fully legalize...

GW Pharmaceuticals (NASDAQ: GWPH) has released what is very possibly its final earnings report as an independent company. On Tuesday, the maker of drugs derived from cannabis published its fourth-quarter results, which revealed that it earned $148 million in revenue for the peri...

It’s time for your Daily Hit of cannabis financial news for February 16, 2021. On The Site GWPH GW Pharmaceuticals plc (Nasdaq: GWPH) announced that the total revenue for the fourth quarter ending December 31, 2020, was $148.2 million versus $1...

GW Pharmaceuticals plc (Nasdaq: GWPH) announced that the total revenue for the fourth quarter ending December 31, 2020, was $148.2 million versus $109.1 million for the quarter ended December 31, 2019. This beat the analyst estimates according to Yahoo Finance by $3.66 million. Th...

The cannabis sector is on fire, enjoying tailwinds from the latest political changes. Canadian LPs' liquidity makes it a great opportunity for traders. MJ vs. MSOS - ETF performance analysis. Despite the better performance in Canadian LPs lately, a bigger opportunity still lie...

GW Pharmaceuticals (GWPH): Q4 GAAP EPS of -$0.08 misses by $0.02.Revenue of $148.2M (+35.8% Y/Y) beats by $3.66M.Press Release For further details see: GW Pharmaceuticals EPS misses by $0.02, beats on revenue

– Total revenue of $148.2 million for the fourth quarter and $527.2 million for the full year – – Total Epidiolex ® net product sales of $144.1 million for the fourth quarter and $510.5 million for the full year – –...

The CBD market has recently seen a multibillion-dollar deal and Hempfusion going public. Co-Founder/CEO Dr. Jason Mitchell and CCO Danny Brody join the show to discuss radical transparency, methodical growth and becoming more efficient during Covid. We also cover the opportunity i...

In the past few months, some big deals have taken place in the cannabis industry. In December 2020, there was news of a near-$4 billion merger including Canadian pot giants Aphria (NASDAQ: APHA) and Tilray (NASDAQ: TLRY) , which will create the largest cannabis company in th...